{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:57:18Z","timestamp":1766087838330,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.nucmedbio.2022.04.004","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T11:09:10Z","timestamp":1649502550000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?"],"prefix":"10.1016","volume":"110-111","author":[{"given":"Kazumi","family":"Chia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowena L.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J.","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marium","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory E.D.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Blower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/bjc.1955.55","article-title":"The histological structure of some human lung cancers and the possible implications for radiotherapy","volume":"IX","author":"Thomlinson","year":"1955","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0010","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1089\/ars.2007.1628","article-title":"Detection and characterization of tumor hypoxia using pO2 histography","volume":"9","author":"Vaupel","year":"2007","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0015","first-page":"941","article-title":"Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma","volume":"56","author":"Brizel","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","article-title":"Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck","volume":"38","author":"Brizel","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0167-8140(96)91811-3","article-title":"Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck","volume":"41","author":"Nordsmark","year":"1996","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0030","first-page":"638","article-title":"The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0035","first-page":"4509","article-title":"Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix","volume":"56","author":"Hockel","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0040","first-page":"73","article-title":"Classification of anti-neoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor-cells","volume":"41","author":"Teicher","year":"1981","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MNM.0b013e32834eacb7","article-title":"Hypoxia imaging with PET: which tracers and why?","volume":"33","author":"Chia","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020070","article-title":"Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD","volume":"2","author":"Haubner","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0055","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1158\/0008-5472.CAN-09-1682","article-title":"Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer","volume":"69","author":"Hillier","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0060","first-page":"670","article-title":"A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection","volume":"21","author":"Som","year":"1980","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbabio.2007.10.010","article-title":"Oxygen sensors in context","volume":"1777","author":"Ward","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"Hockel","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12410-018-9447-3","article-title":"PET imaging of cardiac hypoxia: hitting hypoxia where it hurts","volume":"11","author":"Pell","year":"2018","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijrobp.2013.07.022","article-title":"The tumor radiobiology of SRS and SBRT: are more than the 5 rs involved?","volume":"88","author":"Brown","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s007750100291","article-title":"Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships","volume":"7","author":"Dearling","year":"2002","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2967\/jnumed.113.129015","article-title":"Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM","volume":"55","author":"Handley","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nucmedbio.2004.10.004","article-title":"Investigation into cu-64-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents","volume":"32","author":"McQuade","year":"2005","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0100","first-page":"177","article-title":"Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model","volume":"40","author":"Lewis","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2967\/jnumed.114.148353","article-title":"64Cu-CTS: a promising radiopharmaceutical for the identification of low-grade cardiac hypoxia by PET","volume":"56","author":"Medina","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0110","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/MNM.0000000000001422","article-title":"Production of copper-64 using a hospital cyclotron: targetry, purification and quality analysis","volume":"42","author":"Jauregui-Osoro","year":"2021","journal-title":"Nucl Med Commun"},{"year":"2019","series-title":"Radiotherapy dose fractionation","author":"RCo","key":"10.1016\/j.nucmedbio.2022.04.004_bb0115"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0120","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1126\/science.1082504","article-title":"Tumor response to radiotherapy regulated by endothelial cell apoptosis","volume":"300","author":"Garcia-Barros","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2307\/3577760","article-title":"Characteristics of the binding of labeled fluoromisonidazole in cells-in vitro","volume":"122","author":"Rasey","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2307\/3576294","article-title":"A thin-film culturing technique allowing rapid gas-liquid equilibration (6 sec) with no toxicity to mammalian cells","volume":"97","author":"Koch","year":"1984","journal-title":"Radiat. Res."},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.nucmedbio.2009.01.016","article-title":"Radio-copper-labeled cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model","volume":"36","author":"Oh","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0140","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2967\/jnumed.113.126615","article-title":"A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers","volume":"55","author":"Carlin","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0145","article-title":"Copper-64-diacetyl-bis(N(4)-methylthiosemicarbazone) pharmacokinetics in FaDu xenograft tumors and correlation with microscopic markers of hypoxia","volume":"84","author":"KC","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0150","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.ijrobp.2004.12.057","volume":"61","author":"O'Donoghue","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0155","first-page":"989","article-title":"Intertumoral differences in hypoxia selectivity of the PET imaging agent Cu-64(II)-diacetyl-bis(N-4-methylthiosemicarbazone)","volume":"47","author":"Yuan","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0160","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2307\/3580034","article-title":"Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors","volume":"151","author":"Raleigh","year":"1999","journal-title":"Radiat Res"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0165","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1667\/RR1305.1","article-title":"Importance of antibody concentration in the assessment of cellular hypoxia by flow cytometry: EF5 and pimonidazole","volume":"169","author":"Koch","year":"2008","journal-title":"Radiat Res"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0170","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2967\/jnumed.114.137448","article-title":"Comparison of the hypoxia PET ttacer 18F-EF5 to immunohistochemical marker EF5 in 3 different human tumor xenograft models","volume":"55","author":"Chitneni","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0175","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","article-title":"The expression and distribution of the hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 in Normal human tissues, cancers, and tumor-associated macrophages","volume":"157","author":"Talks","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0185","doi-asserted-by":"crossref","first-page":"C1172","DOI":"10.1152\/ajpcell.1996.271.4.C1172","article-title":"Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension","volume":"271","author":"Jiang","year":"1996","journal-title":"Am J Physiol Cell Physiol"},{"year":"2002","series-title":"Basic Clinical Radiobiology","author":"Steel","key":"10.1016\/j.nucmedbio.2022.04.004_bb0190"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0360-3016(99)00157-1","article-title":"Oxygen tension measurements of tumors growing in mice","volume":"45","author":"Adam","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-8140(98)00044-9","article-title":"Oxygenation predicts radiation response and survival in patients with cervix cancer","volume":"48","author":"Fyles","year":"1998","journal-title":"Radiother Oncol"},{"year":"2019","series-title":"Stereotactic Ablative Body Radiation Therapy: A Resource","author":"Consortium","key":"10.1016\/j.nucmedbio.2022.04.004_bb0205"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0210","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.radonc.2007.05.014","article-title":"Hypoxia-imaging with (18)F-misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer","volume":"83","author":"Eschmann","year":"2007","journal-title":"Radiother Oncol"},{"year":"2006","series-title":"Radiobiology for the radiologist","author":"Hall","key":"10.1016\/j.nucmedbio.2022.04.004_bb0215"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0220","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0360-3016(76)90139-5","article-title":"Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons","volume":"1","author":"Fowler","year":"1976","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0225","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ijrobp.2018.03.045","article-title":"(18)F-EF5 PET-based imageable hypoxia predicts local recurrence in tumors treated with highly conformal radiation therapy","volume":"102","author":"Qian","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0230","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijrobp.2018.05.032","article-title":"High single doses of radiation may induce elevated levels of hypoxia in early-stage non-small cell lung cancer tumors","volume":"102","author":"Kelada","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0235","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3109\/0284186X.2015.1064162","article-title":"Targeting tumour hypoxia to improve outcome of stereotactic radiotherapy","volume":"54","author":"Wittenborn","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0240","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.radonc.2008.02.006","article-title":"A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG study 95\u201302)","volume":"87","author":"Drzymala","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0245","article-title":"Structural trends in copper(II) bis(thiosemicarbazone) radiopharmaceuticals","volume":"4416\u201325","author":"Blower","year":"2003","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nucmedbio.2022.04.004_bb0250","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jlcr.1195","article-title":"Imaging hypoxia in vivo by controlling the electrochemistry of copper radionuclide complexes","volume":"50","author":"Blower","year":"2007","journal-title":"J Labelled Compd Radiopharmaceut"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805122000348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805122000348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:29:59Z","timestamp":1760848199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805122000348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":50,"alternative-id":["S0969805122000348"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.04.004","relation":{},"ISSN":["0969-8051"],"issn-type":[{"type":"print","value":"0969-8051"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}